Cytokine production in depressed patients

Advances in Experimental Medicine and Biology

Volumn 461, Issue , 1999, Pages 47-57

  Seidel, A ^a   Rothermundt, M ^a   Rink, L ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; BRAIN FUNCTION; CELLULAR IMMUNITY; CONFERENCE PAPER; CYTOKINE PRODUCTION; DEPRESSION; HUMAN; INFLAMMATION; LEUKOCYTE ACTIVATION; MONOCYTE; MOOD; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0033282373     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-585-37970-8_3     Document Type: Conference Paper

References (69)

1. Cytokines in neuronal cell types
2. Depressed lymphocyte function after bereavement
3. Blood levels of cytokines in eldery patients with major depressive disorder
4. The acute phase response
5. Depression, stress and immunological activation: The role of cytokines in depressive disorders
6. Viral causes of psychiatric disease
7. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view
8. Interleukin 1 receptors in the brain and endocrine tissues
9. Neutophilia and lymphocytopenia in major mood disorders
10. A critical appraisal of mitogen induced lymphocyte proliferation in depressed patients
11. Direct Stimulation of Cytokines in whole blood. I. Comparison with isolated PBMC stimulation
12. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells
13. Lymphocyte subclasses and depression
14. Circulating natural killer cell phenotypes in men and women with major depression
15. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS
16. Increased rates of depression: Update of epidemiological findings and analytical problems
17. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission
18. Mediators of communication and adaptation in the neuroendocrine and immune systems
19. Clinical and biochemical manifestations of depression - Part I & part II
20. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation
21. The neuroendocrine-immune axis
22. Interactions between cytokines and the nervous system
23. Major depressive disorder, alcoholism and reduced natural killer cell cytotoxicity
24. 2-macroglobulin
25. Elevated levels of acute phase proteins in major depression
26. A survey of serum antibodies to eight common viruses in psychiatric patients
27. A whole blood technique for testing production of human interferon by leukocytes
28. Leukocyte regulation in depression and schizophrenia
29. Unaltered monocyte function in patients with major depession before and after three months of antidepressive therapy
30. Epidemiology of depression: Prevalence, risk factors and treatment situation
31. Immune disturbances during major depression: Upregulated expression of interleukin-2 receptors
32. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor production
33. Evidence for a systemic immune activation during depression: Results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
34. Leukocytosis, monocytosis and neutrophilia: Hallmarks of servere depression
35. Interleukin-1β: A putative mediator of HPA axis hyperactivity in major depression?
36. Relationship between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression
37. Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: Further evidence for an immune response
38. Evidence for an immune response in major depression: A review and hypothesis
39. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistent depression
40. Neutrophil and monocyte phagocytosis in depressed patients
41. Interferons as mediators of psychiatric morbidity
42. Neurological and psychiatric adverse effects of immunological therapy
43. Investigations of the cellular immunity during depression and the free interval: Evidence for an immune activation in active psychosis
44. Inflammatory cytokines in the brain: Does the CNS shape immune responses?
45. Interferon-γ and lipopolysaccharide reduce cAMP response in cultured glial cells: Reversal by type IV phosphodiesterase inhibitor
46. Cytokine regulation of T-cell function: Potential for therapeutic intervention
47. Lymphocyte subsets associated with major depression and dysthymia: Modification by antidepressant treatment
48. Modification of cytokine production by piroxicam
49. Interactions between cytokines and the nervous system
50. Lymphocyte function in major depressive disorder
51. Cytokine production and serum proteins in depression
52. Major depressive disorder is associated with elevated monocyte counts
53. Increased CD56+ natural killer cells and related cytokines in major depression
54. Indicators of immune activation in major depression
55. The macrophage theory of depression
56. Depression, the immune system, and health and illness
57. Measurement of cortisol and lymphocyte subpopulations in depressed and conduct-disordered adolescents
58. Effect of alpha-2-macroglobulin on cytokine-mediated human C-reactive protein production
59. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets
60. Cytokine production in major depressed patients before and after clomipramine treatment
61. Interaction of lymphocytes with cerebral endothelial cells in vitro
62. Cytokines as mediatiors of reactive astrogliosis